11. Co-Morbidity and IBD

Understanding of the effects of concurrent medical conditions on the treatment of IBD


Full content only available after log-in


11.1.  Knows the importance of assessing co-morbidities in patients with IBD

11.2.  Knows the risks relating to a previous history of malignancy or the development of malignancy in IBD, in particular how this affects treatment options.

11.3.  Knows the risks relating to infections such as tuberculosis, hepatitis B, hepatitis C and HIV in relation to the treatment of IBD

11.4.  Knows the circumstances in which patients should be screened for or immunised against infectious diseases before commencing therapy

11.5.  Is aware of the appropriate investigations and vaccination strategy for patients with a new diagnosis of IBD


        
 
Topic:





Programme Phase:



Content Format:








Page: 1 2 3 ()

Topic 11 : Educational update

Bone health in IBD – does it concern paediatricians?

D Turner

ECCO 2017 Barcelona Congress

Webcast + PPT
 


Topic 11 : Educational update

Managing complications associated with anti-TNF therapy

S Ben-Horin

15th IBD Intensive Advanced Course

Webcast + PPT
 


Topic 11 : ECCO Guidelines

Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease


ECCO Guidelines
 


Topic 11.1 : State of the art

The elderly patient with IBD: Should azathioprine ever be used in the elderly? Should the type of surgery be different in an elderly patient?

J Colombel

ECCO 2017 Barcelona Congress

Webcast + PPT
 


Topic 11.2 : State of the art

The use of IBD medicine in patients with cancer: Which treatment should be stopped when cancer is diagnosed? Which treatment to use in a patient with a prior diagnosis with cancer?

L Beaugerie

ECCO 2017 Barcelona Congress

Webcast + PPT
 


Topic 10.1 : 

DOP087: The gut microbiota of pregnant women with Crohns Disease and their babies is associated with abnormalities in the adaptive immune system results from the MECONIUM study

J. Torres

ECCO'18 Vienna

PPT
 


Topic 10.1, 10.3 : 

Managing IBD and pregnancy

I. Dotan

ECCO'18 Vienna

PPT
 


Topic 10.1, 10.3 : 

OP032: Outcome of pregnancies in female IBD patients treated with vedolizumab

A. Moens

ECCO'18 Vienna

Webcast + PPT
 


Topic 11 : 

DOP064: ECCO expert consensus and topical review on treatment exit strategies in Inflammatory Bowel Disease

G. Doherty

ECCO'18 Vienna

PPT
 


Topic 11 : 

DOP090: Risk factors for bacteremia in hospitalized patients with Inflammatory Bowel Disease

I. Goren

ECCO'18 Vienna

PPT
 


Page: 1 2 3 ()